The nicotine inhaler was an effective and safe aid to smoking cessation
Objective
To evaluate the effectiveness and safety of the nicotine inhaler as an adjunct to group support in smoking cessation.
Design
1 year, randomised, double blind, placebo controlled trial.
Setting
Smoking cessation clinic at a university hospital in Göteborg, Sweden.
Patients
247 persons who were ≥20 years of age (mean age 48 y, 64% women), smoked ≥10 cigarettes per day, smoked for ≥3 years, and had made a previous serious attempt to quit smoking using nicotine chewing gum. Exclusion criteria included severe cardiovascular disease; pregnancy; breast feeding; use of psychotropic drugs, smokeless tobacco, or snuff; abuse of alcohol or any other drugs during the past 12 months; nicotine replacement therapy during the past 12 months; and acute medical illness. Follow up was 94%.
Intervention
Participants attended support sessions lasting 45–60 minutes over 6 weeks which included behavioural modification. At the second session, participants were allocated to nicotine …
